SCHEMBL7686884

SCHEMBL7686884

COC(=O)c1ccc(NS(C)(=O)=O)cc1Br

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.55
SMN1; SMN2 Q16637 3/20 0.54
KDM4E B2RXH2 2/20 0.54
HSD17B10 Q99714 1/20 0.54
CHEK1 O14757 1/20 0.50
AURKA O14965 1/20 0.50
DAPK3 O43293 1/20 0.50
JAK2 O60674 1/20 0.50
ABL1 P00519 1/20 0.50
NTRK1 P04629 1/20 0.50
FYN P06241 1/20 0.50
CSF1R P07333 1/20 0.50
RET P07949 1/20 0.50
IGF1R P08069 1/20 0.50
MET P08581 1/20 0.50
PDGFRB P09619 1/20 0.50
PIM1 P11309 1/20 0.50
FGFR1 P11362 1/20 0.50
PRKACA P17612 1/20 0.50
LTK P29376 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1542634 0.88 POLB (0.55) POLBSMN1; SMN2KDM4EHSD17B10CHEK1
SCHEMBL31278515 0.85 HPGD (0.59) POLBSMN1; SMN2KDM4EHSD17B10CHEK1
SCHEMBL11360774 0.84 ALDH1A1 (0.53) POLBSMN1; SMN2KDM4EAURKAKDR
SCHEMBL5324234 0.83 KDM4E (0.59) POLBSMN1; SMN2KDM4EHSD17B10CHEK1
SCHEMBL15754433 0.83 SMN1; SMN2 (0.62) POLBSMN1; SMN2KDM4EHSD17B10CHEK1
SCHEMBL26800515 0.81 KDM4E (0.57) POLBSMN1; SMN2KDM4EHSD17B10CHEK1
SCHEMBL1016778 0.81 POLB (0.55) POLBSMN1; SMN2KDM4EHSD17B10CHEK1
SCHEMBL25452273 0.80 SMN1; SMN2 (0.46) SMN1; SMN2KDM4EHSD17B10ABL1HPGD
SCHEMBL14267852 0.80 SMN1; SMN2 (0.46) POLBSMN1; SMN2KDM4EHSD17B10ABL1
SCHEMBL28017680 0.80 KDM4E (0.60) POLBSMN1; SMN2KDM4EHSD17B10CHEK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020045551-A1 4-benzoyl isoxazoles derivatives and their use as herbicides MUSIL TIBOR (GB) 2002-04-18 US disclosed
US-6323155-B1 EXCELLENT LEVEL OF HERBICIDAL ACTIVITY TOGETHER WITH CROP TOLERANCE RHONE-POULENC AGRICULTURE LIMITED (GB) 2001-11-27 US disclosed
EP-0674629-B1 4-BENZOYL ISOXAZOLES DERIVATIVES AND THEIR USE AS HERBICIDES RHONE POULENC AGRICULTURE (GB) 1998-07-08 EP disclosed
EP-0674629-A1 4-BENZOYL ISOXAZOLES DERIVATIVES AND THEIR USE AS HERBICIDES RHONE-POULENC AGRICULTURE LTD. (GB) 1995-10-04 EP disclosed
WO-1994014782-A1 4-BENZOYL ISOXAZOLES DERIVATIVES AND THEIR USE AS HERBICIDES RHONE-POULENC AGRICULTURE LTD. (GB) 1994-07-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020045551-A1 4-benzoyl isoxazoles derivatives and their use as herbicides CBR3, CBR1, GLRA3 POLB 2653/4885SMN1; SMN2 3433/4885KDM4E 2527/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.